Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 07 Jul 2026 for Vertex Pharmaceuticals INC / MA, €700k. Read the official filing
Filing timeline
BuySaleDuncan McKechnie
Insider track record
Disclosed buys
0
Disclosed sells
3
Signal history
Duncan McKechnie: trading record in brief
Duncan McKechnie discloses dealings in Vertex Pharmaceuticals INC / MA to SEC (Form 4). Between 22 January 2026 and 2 July 2026, the trades on record add up to 8 filings.
Sales make up the whole of the open-market record (3 sales, €2.8M). Other entries cover 5 share grants.
On 7 July 2026 came the latest disclosure, an open-market sale for €700k in Vertex Pharmaceuticals INC / MA. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Duncan McKechnie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
1,541 shares@ US$519.000.0006% mcap100.0% of flowCommon StockSEC:0000875320-26-000243:0
2,633 shares@ US$498.4224.7% of flowCommon StockSEC:0000875320-26-000138:0
2,437 shares@ US$475.3021.8% of flowCommon StockSEC:0000875320-26-000136:0
873 shares@ US$485.117.9% of flowCommon StockSEC:0000875320-26-000116:0
4,962 shares0Common StockSEC:0000875320-26-000094:0
2,283 shares@ US$487.7620.5% of flowCommon StockSEC:0000875320-26-000072:0
1,127 shares@ US$468.419.7% of flowCommon StockSEC:0000875320-26-000048:0
4,720 shares0Common StockSEC:0000875320-26-000022:0
8 of 8 declarations
